The following is a summary of “Paradoxical GH response at OGTT does not predict Pasireotide efficacy but matters for glucose metabolism,” published in the January 2025 issue of Endocrinology by Occhi ...

Chandigarh: Team PGIMER, led by Prof Dhandapani SS, has made groundbreaking advancements in neurosurgery by publishing three ...

When Ray Kohn started feeling pain in his knees and elbows in 2015, he attributed it to his work as a stunt driver and ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) stands ...

Acromegaly is a hormonal disorder in which there is an overproduction of growth hormone. If the disorder begins in puberty, it is called gigantism. Most cases of acromegaly are caused by a benign ...

Despite its valuation, Crinetics' advancements in acromegaly treatment and strong Wall Street backing make it a hold and potential acquisition on pullbacks. ...I consider Crinetics to be ...

A machine learning model was more accurate than 12 experienced endocrinologists in identifying adults with acromegaly based on voice recordings, according to findings published in The Journal of ...

Among patients with endogenous hypercortisolism, relacorilant improved cardiometabolic parameters such as blood pressure, HbA1c and weight, according to results of a long-term extension study ...

Living up to his name, his billed height was over 7 feet, and weighed over 500 pounds. But he was suffering from acromegaly, which was the reason for his huge size. Acromegaly is a hormonal imbalance ...